Millendo Therapeutics snags $62 mln Series B

By Iris Dorbian — 1 month ago

Ann Arbor, Michigan-based Millendo Therapeutics (formerly known as Atterocor Inc), a biopharmaceutical company focused on treating orphan and specialty endocrine diseases, has raised $62 million in Series B funding. New Enterprise Associates Inc led the round. Other investors included Roche Venture Fund, Adams Street Partners, Altitude Life Science Ventures, Longwood Fund, Renaissance Venture Capital Fund, Frazier Healthcare Partners, Osage University Partners and 5AM Ventures.

Continue

Adams Street Partners appoints Soo to helm Asian investment team

By Iris Dorbian — 2 months ago

Adams Street Partners has named Yar-Ping Soo to lead the firm’s Asian investment team. Soo, a partner at Adams Street since 2010, will be succeeding Piau-Voon Wang, who will become a senior advisor. Prior to joining Adams Street, Soo worked at GIC Special Investments where she held various senior investment positions.

Continue

Earnest rakes in $275 mln

By Iris Dorbian — 3 months ago

San Francisco-based tech-focused financial services company Earnest has secured $275 million in funding. Included in this amount is $75 million in a Series B funding round led by Battery Ventures with participation from other investors that included Maveron and Adams Street Partners. The remaining $200 million was from New York Life and unnamed backers.

Continue

Corvus Pharmaceuticals rakes in $75 mln Series B

By Iris Dorbian — 5 months ago

Burlingame, California-based Corvus Pharmaceuticals, a biopharmaceutical company focused on treating cancer, has raised $75 million in Series B funding. Rock Springs Capital Management led the round with participation from other investors that included Fidelity Management and Research Company, Blackrock, Roche Venture Fund, Cormorant Asset Management, venBio Select, Cowen Private Investments, Orbimed, Novo Ventures and Adams Street Partners. Cowen and Company advised Corvus on the transaction.

Continue

ServiceMax pulls in $82 mln Series F

By Iris Dorbian — 6 months ago

Field service management software provider ServiceMax has raised $82 million in Series F funding. Premji Invest led the round with participation from other investors that included GE Ventures, PTC Inc, Cloud Apps Capital, Emergence Capital Partners, KPCB, Mayfield, Meritech, Adams Street Partners, Crosslink Capital, Questmark Partners, Sozo Ventures and Trinity Ventures.

Continue

Investor group buys LP stakes in Palamon funds, commits new capital

By Chris Witkowsky — 6 months ago

Adams Street Partners, Goldman Sachs, Morgan Stanley, PGGM and the Rothschild Merchant Banking Group bought LP stakes in Palamon European Equity Funds I and II as part of a tender offer process. The investor group also committed new capital into a vehicle that will invest alongside Palamon Auxiliary Partnership 2013. Credit Suisse ran the process. The two newer vehicles have committed to the purchase of Currencies Direct in partnership with Corsair Capital.

Continue

Apto nabs $8 mln Series B

By Iris Dorbian — 6 months ago

Denver-based Apto, a brokerage management software provider for the commercial real estate market, has secured $8 million in Series B funding. Adams Street Partners led the round. In conjunction with the funding, Jeffrey Diehl, a managing director at Adams Street Partners, has been appointed to Apto’s board of advisors.

Continue

Orbus Therapeutics racks up $32.5 mln Series A

By Iris Dorbian — 6 months ago

Orbus Therapeutics Inc, a biopharmaceutical company focused on treating rare diseases, has closed $32.5 million in Series A funding. Longitude Capital, H.I.G. BioVentures and Adams Street Partners led the round. Also, the company has named Dr. Ernest Mario, an investor in this current round, as chairman of board.

Continue

Marketing tech platform RadiumOne collects $54 mln

By Iris Dorbian — 8 months ago

San Francisco-based RadiumOne, a marketing technology platform for brands and agencies, has raised $54 million in funding. Harmony Partners led the round with participation from Industry Ventures, Adams Street Partners, Crosslink Capital, Trinity Ventures and DFJ Espirit. RBC Capital Markets served as placement agent for the transaction.

Continue

VC-backed ProNAi files for IPO

By Iris Dorbian — 8 months ago

Vancouver-based ProNAi Therapeutics, a developer of nucleic acid therapeutics, has filed for an IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be set. The stock will list on the NASDAQ under the ticker symbol “DNAI.” Jefferies LLC and BofA Merrill Lynch will serve as the lead underwriters. ProNAi’s backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.

Continue

Health platform Maxwell picks up $26.4 mln

By Iris Dorbian — 1 year ago

Health-as-a-Service platform Maxwell has closed $26.4 million in funding. Adams Street Partners led the round with participation from Cambia Health Solutions, Schooner Capital, Brothers Brook, Vaizra Investments, Tribeca Venture Partners, Catalyst Health Ventures, Serious Change and Lerer Hippeau Ventures.

Continue

VC-backed ProNai adds five to senior management staff

By Iris Dorbian — 1 year ago

ProNAi Therapeutics, a developer of nucleic acid therapeutics, has expanded its senior management team with five additions. Joining the firm are Dr. Angie You as chief business and strategy officer and head of commercial; Wendy Chapman as senior vice president of clinical operations; Chandra Lovejoy as senior vice president of global regulatory affairs and quality; Emma McCann as vice president of program management; and James Smith as vice president of corporate affairs. ProNAi’s backers include Vivo Capital, Frazier Healthcare Ventures, OrbiMed Advisors, Adams Street Partners, RA Capital Management, Caxton Alternative Management, Hopen Life Science Ventures, Sectoral Asset Management and Janus Capital Management.

Continue

Adams Street Partners announces several executive changes

By Iris Dorbian — 1 year ago

Private equity firm Adams Street Partners has made a number of executive changes to its team. The firm has promoted Jeff Diehl to head of investments while Miguel Gonzalo has been named head of investment strategy. Also, Ray Chan has become the head of risk management and advanced analytics. And, Kelly Meldrum, who was recently promoted to head the firm’s primary investment team, has begun to chair the primary investment committee as Chief Investment Officer Hanneke Smits transitions out of her duties.

Continue